Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EFSA considers volunteer Amflora plants safe

The possible emergence of volunteer plants of BASF's genetically modified improved starch Amflora potato in the EU is not an environmental concern, concludes the European Food Safety Authority (EFSA). Such occurrences should be considered as a crop management issue, it adds. The view is based on an analysis of BASF's monitoring report for Amflora in 2012, and the EFSA notes that information is limited due to the company's discontinuation of the GM line in Europe that year. BASF received EU cultivation approval for Amflora in 2010 after a 14-year wait, but decided to halt commercialisation activities two years later due to continuing political hostility to GM crops in Europe (Agrow No 632, p 2). It subsequently decided to continue trials on two other GM potato varieties that were still in the EU registration system, the improved starch line, Modena, and the late blight (Phytophthora infestans)-resistant line, Fortuna (Agrow No 638, p 2).

Topics

What to read next

UsernamePublicRestriction

Register

AG000707

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel